Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22383| Title: | Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Antibiotics, Antineoplastic/*therapeutic use,Antineoplastic Combined Chemotherapy Protocols/*therapeutic use,Breast Neoplasms/*drug therapy/mortality,Deoxycytidine/administration & dosage/adverse effects/*analogs & derivatives,Drug Resistance, Neoplasm,Female,Humans,Middle Aged,Paclitaxel/administration & dosage/adverse effects/*analogs & derivatives,Patient Compliance,Survival Rate,*Taxoids |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/22383 |
| ISSN: | 0735-7907 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/10923097 http://informahealthcare.com/doi/abs/10.3109/07357900009012188 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
